Chinese biotechnology company Hangzhou Diagens Biotechnology is expanding the use of artificial intelligence driven chromosome testing to improve efficiency in in vitro fertilisation and strengthen its commercial growth strategy. The initiative comes as China faces declining birth rates and increasing demand for assisted
China’s pharmaceutical sector is rapidly moving into the global weight loss drug race after the expiration of Novo Nordisk’s semaglutide patent in the country, unlocking a major commercial opportunity for domestic developers. The shift comes as demand for obesity treatments surges worldwide and
Major international pharmaceutical companies are accelerating their expansion in China, signaling a strategic shift toward localized production as global supply chains become more fragmented. AstraZeneca has announced plans to establish new drug manufacturing facilities in Guangzhou and Shanghai, alongside a dedicated innovation centre
AstraZeneca has unveiled a 15 billion dollar investment plan in China, underscoring renewed commercial momentum between Beijing and London as the UK prime minister visits the country. The British Swedish pharmaceutical group said the investment, running through 2030, will expand medicines manufacturing and
China is accelerating its push to become a global leader in nuclear medicine, a field that is rapidly transforming how doctors diagnose and treat cancer. With heavy state-backed investment and a fast-expanding supply of medical isotopes, China sees nuclear medicine as a strategic
China’s biotechnology sector is experiencing unprecedented growth, with startups and research institutions achieving breakthroughs that are capturing global attention. Advances in gene editing, regenerative medicine, diagnostics, and personalized therapies are transforming healthcare and attracting media coverage. This blog explores the most viral biotech
IntroductionChina’s biotech startup ecosystem is experiencing rapid growth, driven by advancements in genomics, therapeutics, medical devices, and personalized medicine. Venture capital, government funding, and corporate investment fuel innovation and expansion. Biotech startups are transforming healthcare, research, and industrial biotechnology while contributing to economic
